Head-to-head · Cost-Efficiency Index
Fitish vs boostAGErx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fitish
Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option.
Visit FitishboostAGErx
Cost-sensitive shoppers prepaying 12 months for low-cost GLP-1.
Visit boostAGErxThe verdict
Fitish and boostAGErx tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Fitish (ranked #92, a hair above #96) — Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option. But boostAGErx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fitish.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fitish | boostAGErx |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $219/mo (microdose tier, plus a separate fee, compounded) | $95/mo (billed every 28 days, compounded) |
| Tirzepatide / mo | $339/mo (microdose tier, compounded) | $145/mo (billed every 28 days, compounded) |
| Semaglutide / yr (modeled) | $2,628 | $1,140 |
| Tirzepatide / yr (modeled) | $4,068 | $1,740 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #92 | #96 |
Fitish
69/100Where the value is
- Price genuinely includes consult, medication, and shipping — confirmed in the product page's own text, not just marketing copy
- A real microdose tier exists at a meaningfully lower fixed price for both drugs
- Injectable and oral tablet formats both offered
The tradeoffs
- No stated minimum commitment or cancellation terms found on the product pages
- No named prescriber, medical director, or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to FITISH in June 2026. We still list and link to Fitish; you should know the letter is on the public record before you decide.
boostAGErx
69/100Where the value is
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
The tradeoffs
- Billing runs on a 28-day cycle rather than a calendar month — thirteen charges a year, so the $145 tirzepatide rate is $1,885 a year, an effective $157/mo
- The terms call the charge a 'membership fee' while the marketing carousel says 'No Membership Fees Ever'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.